Basaglar Kwikpen Solution for Injection (3ml pre-filled pen)
As low as
$48.06
In stock
Only %1 left
SKU
CMS8585
What is Basaglar KwikPen 100 unit/ml
Basaglar KwikPen 100 unit/ml contains FDA-approved Insulin Glargine, a long-acting basal Insulin analog. This prescription medication helps manage blood glucose levels in adults and children above 2 with Type 1 Diabetes and adults with Type 2 Diabetes.
The pen-injector delivers precise doses ranging from 1-80 units per injection. Eli Lilly and Company manufactures this trusted Insulin therapy solution in GMP-compliant facilities. The medication provides 24-hour glucose control with once-daily dosing.
Each 3ml pen contains 300 units of Insulin Glargine in a clear, colorless solution.
Common Basaglar side effects include injection site reactions, Hypoglycemia, and weight gain. Store unopened pens in the refrigerator between 36-46°F.
Once in use, keep at room temperature below 86°F for a maximum of 28 days. Never freeze or shake the pen. Always prime before first use and rotate injection sites to prevent lipodystrophy.
Monitor blood sugar regularly and adjust dosage only under medical supervision. Dispose of used pens safely in sharps containers.
What are the benefits of Basaglar KwikPen 100 unit/ml
Basaglar KwikPen 100 unit/ml provides consistent 24-hour basal Insulin coverage through its advanced Insulin Glargine formulation. This long-acting Insulin mimics natural basal Insulin secretion, maintaining steady glucose levels between meals and overnight.
The KwikPen delivery system offers convenient, accurate dosing with easy-to-read dose windows. Pre-filled pens eliminate vial handling and reduce dosing errors.
Key therapeutic benefits include improved glycemic control, reduced risk of diabetic complications, and flexible meal timing. Compared to intermediate-acting Insulin, the predictable absorption profile minimizes nocturnal Hypoglycemia.
Clinical studies demonstrate effective HbA1c reduction while maintaining safety profiles. The pen's portability supports active lifestyles and travel convenience for Diabetes management.
How to take Basaglar KwikPen 100 unit/ml
Basaglar KwikPen 100 unit/ml is a prescription medication administered once daily at the same time. Always follow your doctor's instructions for safe administration. If you are not trained to use it, seek medical guidance.
Here are the general guidelines:
- Inject subcutaneously in the thigh, upper arm, or abdomen. Rotate injection sites within the same region to prevent tissue damage.
- Prime pen with 2 units before the first use of each new pen. Inject immediately after dose selection to prevent insulin leakage. Do not dilute or mix with other Insulins.
- Do not exceed the prescribed dosage.
Strengths and substitutes
The strengths and substitutes available for Basaglar are:
| Glaritus 100 IU/ml Injection | $98.31/injection |
| Glaritus 40 IU/ml Injection | $71.38/injection |
What are the side effects of Basaglar KwikPen 100 unit/ml
Basaglar KwikPen 100 unit/ml is generally well-tolerated when used appropriately.
However, it may cause side effects, including:
- Hypoglycemia (low blood sugar)
- Redness
- Swelling
- Itching
- Weight gain
- Peripheral edema
These adverse effects typically resolve as your body adjusts to treatment. Severe Hypoglycemia or persistent effects require immediate medical attention.
Safety Advice
Liver disease
Patients with hepatic impairment may require reduced Insulin doses due to decreased glucose production and slower Insulin metabolism. Regular blood glucose monitoring is essential. Liver function affects Insulin clearance, potentially increasing Hypoglycemia risk. Consult healthcare providers for appropriate dose adjustments.
Kidney impairment
Renal dysfunction can alter Insulin requirements and increase Hypoglycemia risk. Patients with kidney disease need frequent glucose monitoring and potential dose reductions. Insulin elimination decreases with declining kidney function. Medical supervision ensures safe and effective Diabetes management.
Pregnant and breastfeeding women
Basaglar KwikPen 100 unit/ml is generally safe during pregnancy for managing Diabetes. Insulin requirements often change throughout pregnancy, requiring close monitoring. Breastfeeding mothers may need dose adjustments as lactation affects glucose metabolism. Regular consultation with healthcare providers ensures optimal outcomes.
Avoid
Avoid alcohol consumption as it can mask Hypoglycemia symptoms and affect blood glucose levels. Do not skip meals after an Insulin injection to prevent dangerous blood sugar drops. Avoid extreme temperature exposure to the pen. Certain medications like beta-blockers may mask Hypoglycemia warning signs.
FAQs
How long does an opened Basaglar KwikPen last?
Once opened and first used, store the pen at room temperature below 86°F for a maximum of 28 days. After this period, discard the pen even if Insulin remains in it. Never use expired Insulin, as it may not effectively control blood sugar.
Can I reuse needles with my Basaglar KwikPen?
No, never reuse needles as this increases infection risk, causes needle blockages, and delivers inaccurate doses. Always use a new, sterile needle for each injection. Remove and dispose of needles immediately after use in proper sharps containers for safety.
What should I do if I miss my daily Basaglar dose?
Take the missed dose of Basaglar as soon as you remember, then continue with the regular schedule the next day. Skip it if it's close to the next dose. Never take double doses to compensate. If you frequently forget doses, set daily reminders or consult your healthcare provider about timing strategies.
Can I travel with my Basaglar KwikPen on airplanes?
Yes, carry your Basaglar KwikPen in carry-on luggage with prescription labels. Bring extra supplies and a doctor's letter explaining your medical needs. Never store pens in checked luggage due to temperature extremes that can damage the Insulin.
How do I know if my Basaglar KwikPen is working properly?
Monitor your blood glucose levels regularly as directed by your healthcare provider. Consistent readings within target ranges indicate effective treatment. If you experience frequent high or low blood sugars, consult your doctor for potential dose adjustments or pen evaluation.